Trials / Completed
CompletedNCT05550805
Prognostic Study of Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease Based on Metabolomics, and Lipidomics (BIPass II)
Prognostic Study of Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease Based on Metabolomics, and Lipidomics
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,822 (actual)
- Sponsor
- Qilu Hospital of Shandong University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To investigate whether there were differences in metabolomics and lipidomics in patients with coronary artery disease who had major adverse cardiovascular events during follow-up compared with those who did not.
Conditions
Timeline
- Start date
- 2017-11-01
- Primary completion
- 2022-03-01
- Completion
- 2022-03-01
- First posted
- 2022-09-22
- Last updated
- 2025-05-31
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05550805. Inclusion in this directory is not an endorsement.